Search

Lebwohl, Mark, Bruce Strober, Alan Menter, Kenneth Gordon, Jolanta Weglowska, Lluís Puig, Kim Papp, et al. 2015. “Phase 3 Studies Comparing Brodalumab With Ustekinumab in Psoriasis.”. The New England Journal of Medicine 373 (14): 1318-28.

Papp, K A, M A Menter, M Abe, B Elewski, S R Feldman, A B Gottlieb, R Langley, et al. 2015. “Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Chronic Plaque Psoriasis: Results from Two Randomized, Placebo-Controlled, Phase III Trials.”. The British Journal of Dermatology 173 (4): 949-61.

Kauf, Teresa L, Jui-Chen Yang, Alexa B Kimball, Murali Sundaram, Yanjun Bao, Martin Okun, Parvez Mulani, Brett Hauber, and Reed Johnson. 2015. “Psoriasis Patients’ Willingness to Accept Side-Effect Risks for Improved Treatment Efficacy.”. The Journal of Dermatological Treatment 26 (6): 507-13.

Shlyankevich, Julia, Nehal N Mehta, James G Krueger, Bruce Strober, Johann E Gudjonsson, Abrar A Qureshi, Paul W Tebbey, and Alexandra Boer Kimball. 2014. “Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-Related Comorbidities.”. The American Journal of Medicine 127 (12): 1148-53.

Martin, Mona L, Kelly P McCarrier, Chiun-Fang Chiou, Kenneth Gordon, Alexa B Kimball, Abby S Van Voorhees, Alice B Gottlieb, et al. 2013. “Early Development and Qualitative Evidence of Content Validity for the Psoriasis Symptom Inventory (PSI), a Patient-Reported Outcome Measure of Psoriasis Symptom Severity.”. The Journal of Dermatological Treatment 24 (4): 255-60.

Kimball, Alexa B, David Pariser, Paul S Yamauchi, Alan Menter, Craig F Teller, Yifei Shi, Mellissa Yong, et al. 2013. “OBSERVE-5 Interim Analysis: An Observational Postmarketing Safety Registry of Etanercept for the Treatment of Psoriasis.”. Journal of the American Academy of Dermatology 68 (5): 756-64.

Kimball, Alexandra B, Murali Sundaram, Martin Cloutier, Marjolaine Gauthier-Loiselle, Patrick Gagnon-Sanschagrin, Annie Guérin, and Arijit Ganguli. 2018. “Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis.”. Journal of Drugs in Dermatology : JDD 17 (2): 180-86.

Osier, Emily, Audrey S Wang, Megha M Tollefson, Kelly M Cordoro, Stephen R Daniels, Andrew Eichenfield, Joel M Gelfand, et al. 2017. “Pediatric Psoriasis Comorbidity Screening Guidelines.”. JAMA Dermatology 153 (7): 698-704.

Danesh, M J, E B Koo, and A B Kimball. 2016. “Effects of TNF-Alpha Antagonism in Patients With Metabolic Syndrome and Psoriasis.”. Journal of the European Academy of Dermatology and Venereology : JEADV 30 (11): e152-e154.

Clowse, Megan E B, Steven R Feldman, John D Isaacs, Alexandra B Kimball, Vibeke Strand, Richard B Warren, Daniel Xibillé, et al. 2016. “Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.”. Drug Safety 39 (8): 755-62.